Prelude Therapeutics PRLD
NASDAQ PRLD
$3.53 +0.14 (+4.13%)
At close: Oct 20, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Current Leases (2019 - 2025)

Updated

Prelude Therapeutics (PRLD) posted Current Leases of $53,000 for Q1 2025, down 74.5% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Current Leases (2019 - 2025) Analysis & Trends

At the end of FY2024, Prelude Therapeutics' Current Leases came in at $208,000.

  • Annual Current Leases shows a five-year compound annual growth rate of -4.2% (FY2019 to FY2024).
  • According to Business Quant data, Current Leases for the three prior quarters was $208,000 (Q4 2024), $359,000 (Q3 2024) and $507,000 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Prelude Therapeutics 347.31 Mn -249.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 53,000.00
Dec 31, 2024 208,000.00
Sep 30, 2024 359,000.00
Jun 30, 2024 507,000.00
Dec 31, 2019 258,000.00
API Access

Prelude Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=PRLD&period=max&api_key=YOUR_API_KEY